| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
16.52
|
|
2
|
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
|
Circulation
|
2010
|
13.28
|
|
3
|
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
10.24
|
|
4
|
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction.
|
Circulation
|
2007
|
5.09
|
|
5
|
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
|
Circulation
|
2013
|
5.02
|
|
6
|
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
3.63
|
|
7
|
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.
|
J Am Coll Cardiol
|
2003
|
3.55
|
|
8
|
End-stage renal disease predicts complications in pacemaker and ICD implants.
|
J Cardiovasc Electrophysiol
|
2011
|
3.21
|
|
9
|
Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
|
Circulation
|
2004
|
3.20
|
|
10
|
The mitochondrial origin of postischemic arrhythmias.
|
J Clin Invest
|
2005
|
3.08
|
|
11
|
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
|
J Am Coll Cardiol
|
2008
|
2.99
|
|
12
|
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.
|
Circulation
|
2005
|
2.80
|
|
13
|
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).
|
Circulation
|
2003
|
2.68
|
|
14
|
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy.
|
JACC Cardiovasc Imaging
|
2008
|
2.64
|
|
15
|
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
|
Circ Cardiovasc Imaging
|
2012
|
2.62
|
|
16
|
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
|
Circulation
|
2009
|
2.55
|
|
17
|
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis.
|
Am J Epidemiol
|
2011
|
2.38
|
|
18
|
The future of fellowship training in clinical cardiac electrophysiology: Program directors' perspective 2008.
|
Heart Rhythm
|
2009
|
2.22
|
|
19
|
Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.
|
Circ Res
|
2004
|
2.19
|
|
20
|
Post-transcriptional gene silencing of KChIP2 and Navbeta1 in neonatal rat cardiac myocytes reveals a functional association between Na and Ito currents.
|
J Mol Cell Cardiol
|
2008
|
2.09
|
|
21
|
Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.
|
Circulation
|
2009
|
2.09
|
|
22
|
Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association.
|
Circulation
|
2011
|
2.05
|
|
23
|
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
|
J Am Coll Cardiol
|
2010
|
1.97
|
|
24
|
Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI.
|
Circ Arrhythm Electrophysiol
|
2011
|
1.95
|
|
25
|
Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.94
|
|
26
|
Na+ channel regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes.
|
Cardiovasc Res
|
2009
|
1.88
|
|
27
|
Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients.
|
Heart Rhythm
|
2010
|
1.85
|
|
28
|
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.
|
Arch Intern Med
|
2011
|
1.73
|
|
29
|
Modulation of Kv4.3 current by accessory subunits.
|
FEBS Lett
|
2002
|
1.72
|
|
30
|
Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model.
|
Circulation
|
2006
|
1.70
|
|
31
|
Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure.
|
Circ Cardiovasc Genet
|
2011
|
1.68
|
|
32
|
Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization.
|
Circulation
|
2008
|
1.67
|
|
33
|
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
|
Circulation
|
2012
|
1.65
|
|
34
|
Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.
|
Circulation
|
2009
|
1.63
|
|
35
|
Electrocardiographic QT interval and mortality: a meta-analysis.
|
Epidemiology
|
2011
|
1.62
|
|
36
|
Isoform-specific modulation of voltage-gated Na(+) channels by calmodulin.
|
Circ Res
|
2002
|
1.62
|
|
37
|
Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
|
J Mol Cell Cardiol
|
2009
|
1.60
|
|
38
|
Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.
|
Heart Rhythm
|
2012
|
1.60
|
|
39
|
Regulation of Kv4.3 current by KChIP2 splice variants: a component of native cardiac I(to)?
|
Circulation
|
2002
|
1.59
|
|
40
|
ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
|
Circ Arrhythm Electrophysiol
|
2008
|
1.55
|
|
41
|
Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure.
|
J Mol Cell Cardiol
|
2005
|
1.54
|
|
42
|
Electrical remodeling in the failing heart.
|
Curr Opin Cardiol
|
2010
|
1.51
|
|
43
|
Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level.
|
Circ Cardiovasc Genet
|
2009
|
1.51
|
|
44
|
Regional alterations in protein expression in the dyssynchronous failing heart.
|
Circulation
|
2003
|
1.49
|
|
45
|
Evidence for electrical remodeling of the native conduction system with cardiac resynchronization therapy.
|
Pacing Clin Electrophysiol
|
2007
|
1.47
|
|
46
|
Molecular basis of arrhythmias.
|
Circulation
|
2005
|
1.46
|
|
47
|
Subcellular structures and function of myocytes impaired during heart failure are restored by cardiac resynchronization therapy.
|
Circ Res
|
2012
|
1.44
|
|
48
|
Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease.
|
J Cardiovasc Electrophysiol
|
2009
|
1.43
|
|
49
|
Ultrastructure and regulation of lateralized connexin43 in the failing heart.
|
Circ Res
|
2010
|
1.40
|
|
50
|
Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort.
|
Heart Rhythm
|
2013
|
1.40
|
|
51
|
Molecular correlates of altered expression of potassium currents in failing rabbit myocardium.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.39
|
|
52
|
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals.
|
PLoS Genet
|
2011
|
1.38
|
|
53
|
Pathophysiological basis and clinical application of T-wave alternans.
|
J Am Coll Cardiol
|
2002
|
1.37
|
|
54
|
Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts.
|
Circ Res
|
2003
|
1.35
|
|
55
|
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts.
|
Circ Cardiovasc Genet
|
2009
|
1.32
|
|
56
|
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
J Am Coll Cardiol
|
2010
|
1.31
|
|
57
|
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
|
J Am Heart Assoc
|
2013
|
1.30
|
|
58
|
Non-equilibrium behavior of HCN channels: insights into the role of HCN channels in native and engineered pacemakers.
|
Cardiovasc Res
|
2005
|
1.28
|
|
59
|
Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts.
|
Cardiovasc Res
|
2005
|
1.26
|
|
60
|
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
|
Am J Gastroenterol
|
2010
|
1.24
|
|
61
|
Mechanisms of disease: ion channel remodeling in the failing ventricle.
|
Nat Clin Pract Cardiovasc Med
|
2008
|
1.24
|
|
62
|
Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito.
|
Am J Physiol Heart Circ Physiol
|
2003
|
1.22
|
|
63
|
Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes.
|
Genomics
|
2004
|
1.22
|
|
64
|
Transmural heterogeneity of Na+-Ca2+ exchange: evidence for differential expression in normal and failing hearts.
|
Circ Res
|
2005
|
1.16
|
|
65
|
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes.
|
Circulation
|
2010
|
1.15
|
|
66
|
Risk stratification for sudden cardiac death: a plan for the future.
|
Circulation
|
2014
|
1.14
|
|
67
|
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
Circulation
|
2010
|
1.12
|
|
68
|
Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.
|
PLoS One
|
2010
|
1.09
|
|
69
|
Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart.
|
Sci Transl Med
|
2011
|
1.08
|
|
70
|
A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral.
|
J Electrocardiol
|
2010
|
1.07
|
|
71
|
Molecular motions of the outer ring of charge of the sodium channel: do they couple to slow inactivation?
|
J Gen Physiol
|
2003
|
1.07
|
|
72
|
Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.05
|
|
73
|
Predictors of high defibrillation threshold in the modern era.
|
Pacing Clin Electrophysiol
|
2012
|
1.05
|
|
74
|
Ventricular arrhythmia is predicted by sum absolute QRST integralbut not by QRS width.
|
J Electrocardiol
|
2010
|
1.02
|
|
75
|
Calmodulin regulation of Nav1.4 current: role of binding to the carboxyl terminus.
|
J Gen Physiol
|
2008
|
1.00
|
|
76
|
Mechanisms of gap junction traffic in health and disease.
|
J Cardiovasc Pharmacol
|
2009
|
1.00
|
|
77
|
Calcium-mediated dual-mode regulation of cardiac sodium channel gating.
|
Circ Res
|
2009
|
1.00
|
|
78
|
A 14-3-3 mode-1 binding motif initiates gap junction internalization during acute cardiac ischemia.
|
Traffic
|
2014
|
0.99
|
|
79
|
Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mapping.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.98
|
|
80
|
Molecular basis of isoform-specific micro-conotoxin block of cardiac, skeletal muscle, and brain Na+ channels.
|
J Biol Chem
|
2002
|
0.98
|
|
81
|
Conduction abnormalities in nonischemic dilated cardiomyopathy: basic mechanisms and arrhythmic consequences.
|
Trends Cardiovasc Med
|
2005
|
0.97
|
|
82
|
Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure.
|
Am J Physiol Heart Circ Physiol
|
2005
|
0.96
|
|
83
|
Two-photon laser scanning microscopy of the transverse-axial tubule system in ventricular cardiomyocytes from failing and non-failing human hearts.
|
Cardiol Res Pract
|
2010
|
0.95
|
|
84
|
Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study.
|
Radiology
|
2008
|
0.94
|
|
85
|
Complex assessment of the temporal lability of repolarization.
|
Int J Cardiol
|
2012
|
0.93
|
|
86
|
Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels.
|
Mol Pharmacol
|
2003
|
0.93
|
|
87
|
Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey.
|
PLoS One
|
2011
|
0.92
|
|
88
|
A conserved ring of charge in mammalian Na+ channels: a molecular regulator of the outer pore conformation during slow inactivation.
|
J Physiol
|
2006
|
0.91
|
|
89
|
Desmin modifications associate with amyloid-like oligomers deposition in heart failure.
|
Cardiovasc Res
|
2014
|
0.90
|
|
90
|
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
|
Heart Rhythm
|
2010
|
0.89
|
|
91
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2012
|
0.89
|
|
92
|
Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.
|
Physiol Genomics
|
2008
|
0.89
|
|
93
|
Charge conversion enables quantification of the proximity between a normally-neutral mu-conotoxin (GIIIA) site and the Na+ channel pore.
|
FEBS Lett
|
2002
|
0.89
|
|
94
|
Ion channels as novel therapeutic targets in heart failure.
|
Ann Med
|
2005
|
0.88
|
|
95
|
Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.87
|
|
96
|
A multifunctional aromatic residue in the external pore vestibule of Na+ channels contributes to the local anesthetic receptor.
|
Mol Pharmacol
|
2005
|
0.87
|
|
97
|
Cardiac metabolism and arrhythmias.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.87
|
|
98
|
Reciprocal regulation of metabolic and signaling pathways.
|
BMC Genomics
|
2010
|
0.87
|
|
99
|
Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.
|
Heart Rhythm
|
2012
|
0.86
|
|
100
|
Dependence of mu-conotoxin block of sodium channels on ionic strength but not on the permeating [Na+]: implications for the distinctive mechanistic interactions between Na+ and K+ channel pore-blocking toxins and their molecular targets.
|
J Biol Chem
|
2003
|
0.86
|
|
101
|
The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association.
|
Circulation
|
2011
|
0.86
|
|
102
|
Troponin-I elevation in a young man with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
J Interv Card Electrophysiol
|
2008
|
0.85
|
|
103
|
Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.83
|
|
104
|
Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC.
|
J Clin Endocrinol Metab
|
2011
|
0.81
|
|
105
|
Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels.
|
Mol Pharmacol
|
2002
|
0.81
|
|
106
|
Using the deadly mu-conotoxins as probes of voltage-gated sodium channels.
|
Toxicon
|
2004
|
0.81
|
|
107
|
Mechanisms of a human skeletal myotonia produced by mutation in the C-terminus of NaV1.4: is Ca2+ regulation defective?
|
PLoS One
|
2013
|
0.81
|
|
108
|
Cardiac I(to), KCNE2, and Brugada syndrome: promiscuous subunit interactions, or what happens in HEK cells stays in HEK cells?
|
Heart Rhythm
|
2009
|
0.80
|
|
109
|
Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia.
|
Pacing Clin Electrophysiol
|
2003
|
0.80
|
|
110
|
Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT.
|
J Cardiovasc Transl Res
|
2012
|
0.80
|
|
111
|
Baseline Troponin T Levels Modulate the Effects of ICD Shocks on All-Cause Mortality.
|
J Am Coll Cardiol
|
2015
|
0.80
|
|
112
|
Significance of leukocytosis after cardiac device implantation.
|
Am J Cardiol
|
2013
|
0.79
|
|
113
|
Novel molecular determinants in the pore region of sodium channels regulate local anesthetic binding.
|
Mol Pharmacol
|
2009
|
0.79
|
|
114
|
Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.
|
Am J Cardiol
|
2012
|
0.79
|
|
115
|
QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance.
|
Magn Reson Med
|
2010
|
0.79
|
|
116
|
Task force 7: training in cardiovascular research.
|
J Am Coll Cardiol
|
2008
|
0.79
|
|
117
|
Left ventricular mechanical dyssynchrony by cardiac magnetic resonance is greater in patients with strict vs nonstrict electrocardiogram criteria for left bundle-branch block.
|
Am Heart J
|
2013
|
0.78
|
|
118
|
The year in arrhythmias--2007: Part I.
|
Heart Rhythm
|
2008
|
0.78
|
|
119
|
Cell surface expression of a specific antigenic site on the catalytic subunit of (Na(+) + K(+))-ATPase.
|
Biochem Biophys Res Commun
|
2002
|
0.78
|
|
120
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2012
|
0.77
|
|
121
|
Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.77
|
|
122
|
Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.77
|
|
123
|
Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Ann Noninvasive Electrocardiol
|
2013
|
0.77
|
|
124
|
Ventricularization of atrial gene expression in the fibrillating heart?
|
Circ Res
|
2005
|
0.77
|
|
125
|
Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study.
|
BMC Nephrol
|
2014
|
0.77
|
|
126
|
LQTS: better with age?
|
J Cardiovasc Electrophysiol
|
2008
|
0.76
|
|
127
|
The year in arrhythmias--2009: part I.
|
Heart Rhythm
|
2009
|
0.76
|
|
128
|
Isoform-specific effects of a novel BmK 11(2) peptide toxin on Na channels.
|
Toxicon
|
2003
|
0.76
|
|
129
|
Localization of myocardial scar in patients with cardiomyopathy and left bundle branch block using electrocardiographic Selvester QRS scoring.
|
J Electrocardiol
|
2013
|
0.75
|
|
130
|
Speaking with one voice on worksite wellness: the American Cancer Society, the American Diabetes Association, and the American Heart Association.
|
Am J Health Promot
|
2011
|
0.75
|
|
131
|
Deciphering gene expression profiling in cardiac resynchronization therapy.
|
J Am Coll Cardiol
|
2008
|
0.75
|
|
132
|
Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.
|
Pacing Clin Electrophysiol
|
2010
|
0.75
|
|
133
|
Cell-based therapy of cardiac arrhythmias: designer cables and Zeno's paradox.
|
Heart Rhythm
|
2010
|
0.75
|
|
134
|
Calcium and arrhythmias: ignore at your peril.
|
J Cardiovasc Electrophysiol
|
2012
|
0.75
|
|
135
|
Pacing-induced remodeling of the ventricle: fire in the matrix.
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
|
136
|
Thyroid hormones and electrocardiographic parameters: findings from the third national health and nutrition examination survey.
|
PLoS One
|
2013
|
0.75
|
|
137
|
Origins of medical innovation: the case of coronary artery stents.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.75
|
|
138
|
Letter by Tomaselli and Holmes regarding article, "2011 ASA/ACCF/AHA/AANN/AANS/ACR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease".
|
Circulation
|
2012
|
0.75
|
|
139
|
A failure to adapt: ankyrins in congenital and acquired arrhythmias.
|
Circulation
|
2007
|
0.75
|
|
140
|
Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram.
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
|
141
|
Evolution of content - the Concise Communication.
|
J Clin Invest
|
2017
|
0.75
|
|
142
|
Profound hypotension due to slow atrioventricular nodal pathway conduction during atrial tachycardia.
|
Pacing Clin Electrophysiol
|
2009
|
0.75
|
|
143
|
The year in arrhythmias 2007: Part II.
|
Heart Rhythm
|
2008
|
0.75
|
|
144
|
Impact through discovery: a global challenge: Presidential Address at the American Heart Association 2011 Scientific Sessions.
|
Circ Res
|
2012
|
0.75
|
|
145
|
A change in editorship.
|
J Clin Invest
|
2017
|
0.75
|
|
146
|
The year in arrhythmias-2009 part II.
|
Heart Rhythm
|
2010
|
0.75
|
|
147
|
Inappropriate implantable cardioverter-defibrillator discharge associated with a new ventricular tachycardia treatment algorithm.
|
Heart Rhythm
|
2007
|
0.75
|
|
148
|
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
149
|
ACCF and AHA Presidents' Letter on MEDCAC.
|
J Am Coll Cardiol
|
2012
|
0.75
|